Top Abstract Purchase Related
Home
>
Node
>
Subnode

Oral steroid contraception

Sech, L.A.; Mishell, D.R.

Women's Health 11(6): 743-748

2015

ISSN/ISBN: 1745-5057
PMID: 26673988
DOI: 10.2217/whe.15.82
Document Number: 642176
Oral steroid contraception is a popular method of family planning worldwide. Over the past several decades, this method of contraception has changed significantly by decreasing the estrogen dose, changing the progestin component, and reducing the hormone free interval. Despite the popularity of oral steroid contraception, there has been much criticism regarding the associated risks of venous thromboembolism and stroke. Despite these established, yet uncommon risks, oral steroid contraception has many important health benefits. This review highlights the available formulations of oral contraceptives along with their evidence-based associated risks and benefits. Highlights regarding future directions for development of novel oral contraceptives are also addressed.

Document emailed within 0-6 h
Secure & encrypted payments

Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Ryder, N.B.; Westoff, C.F. 1966: Use of oral contraception in the United States, 1965. in only 5 years oral contraception has become a major means of regulating fertility Science 153(3741): 1199-1205
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Bhatnagar, S.; Srivastava, U.K.; Takkar, D.; Chandra, V.L.; Hingorani, V.; Laumas, K.R. 1975: Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women Contraception 11(5): 505-521
Jamin, C.; Lachowsky, M. 2015: Place of persistence trouble during oral contraception and subsequent use of emergency contraception Journal de Gynecologie Obstetrique et Biologie de la Reproduction 44(8): 706-714
Chanu, B. 1993: Combined oral estrogen / progestin contraception: practical attitude. Vascular attacks and contraception Arteres et Veines 12(3): 176-179
Chanu, B. 1993: Combined oral estrogen / progestin contraception: practical attitude. Vascular attacks and contraception Arteres et Veines 12(3): 176-179
van de Wijgert, J.H.H.M.; Verwijs, M.C.; Turner, A.Norris.; Morrison, C.S. 2013: Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission Aids 27(13): 2141-2153
Baudet, J.H.; Bothorel, P.; Denax, A. 1990: Contraception hormonale et stérilet: les «petits ennuis» - Disorders induced by oral contraception and intrauterine device Gazette Medicale de France (1969) 97(14): 25-28
Grimes, D.A.; Lopez, L.M.; Gallo, M.F.; Halpern, V.; Nanda, K.; Schulz, K.F. 2007: Steroid hormones for contraception in men Cochrane Database of Systematic Reviews 2: Cd004316
Appertflory, A.; Fischer, F.; Toulon, P. 2005: Contraception orale estroprogestative et thrombophilie : Contraception : mise au point sur les nouveautés et les difficultés - Oral contraceptives and risk of venous thrombosis la Lettre du Gynecologue (300): 36-39
Who Sci Group 1978: Steroid contraception and the risk of neoplasia World Health Organization technical report series 1978(619): 1-54